Skip to main content
. Author manuscript; available in PMC: 2015 Jan 2.
Published in final edited form as: JAMA. 2014 Jul 2;312(1):36–47. doi: 10.1001/jama.2014.6490

Table 1.

Demographic and Injury Characteristics of Patients

Factor 1
(Epo Study Drug)
Factor 2a
(Transfusion Threshold)

Epo 1
Regimen
(n=38)
Epo 2
Regimen
(n=64)
Placebo
(n=98)
Transfusion
Threshold
7 g/dl
(n=99)
Transfusion
Threshold
10 g/dl
(n=101)

DEMOGRAPHIC CHARACTERISTICS

Age, median (25th-75th) 31·5
(23-48)
29
(23-47)
30
(22-44)
28
(21-48)
31
(24-45)

Gender, n (%)
 Female 4 (10·5) 8 (12·5) 14 (14·3) 14 (14.1) 12 (11.9)
 Male 34 (89·5) 55 (85·9) 84 (85·7) 85 (85.9) 88 (87.1)
 Male living as female 1 (1·6) 1 (1.0)

Race/Ethnicity, n (%)
 Asian 1 (2·6) 1 (1·6) 4 (4·1) 3 (3.0) 3 (3.0)
 Hispanic 20 (52·6) 35 (54·7) 48 (49·0) 50 (50.5) 53 (52.5)
 Black 7 (18·4) 10 (15·6) 26 (26·5) 20 (20.2) 23 (22.8)
 White, non-Hispanic 10 (26·3) 18 (28·1) 20 (20·4) 26 (26.3) 22 (21.8)

BASELINE INJURY CHARACTERISTICS

Mechanism of Injury, n (%)
 Assault 2 (5·3) 5 (7·8) 15 (15·3) 7 (7.1) 15 (14.9)
 Fall/jump 11 (28·9) 7 (10·9) 9 (9·2) 18 (18.2) 9 (8.9)
 Automobile accident 19 (50) 41 (64·1) 56 (57·1) 58 (58.6) 58 (57.4)
 Motorcycle accident 5 (13·2) 11 (17·2) 15 (15·3) 14 (14.1) 17 (16.8)
 Other 1 (2·6) 0 3 (3·1) 2 (2.0) 2 (2.0)

Enrollment motor GCSb, n (%)
 4-5 26 (68·4) 38 (59·4) 65 (66·3) 63 (63.6) 66 (65.4)
 1-3 12 (31·6) 26 (40·6) 33 (33·7) 36 (36.4) 35 (34.7)

ED pupil reactivity, n (%)
 Both reactive 25 (65·8) 41 (64·1) 55 (56·1) 63 (63.6) 58 (57.4)
 One reactive 5 (13·2) 5 (7·8) 13 (13·3) 14 (14.1) 9 (8.9)
 Neither reactive 8 (21·1) 18 (28·1) 30 (30·6) 22 (22.2) 34 (33.7)

Enrollment sum GCSc, n (%)
 GCS > 8 18 (47.4) 29 (45.3) 42 (42.9) 42 (42.4) 47 (46.5)
 GCS 6-8 8 (21.1) 12 (18.8) 25 (25.5) 23 (23.2) 22 (21.8)
 GCS 3-5 12 (31.6) 23 (35.9) 31 (31.6) 34 (34.3) 32 (31.7)

ED Marshall CT scan category, n
(%)
 Diffuse injury 1 or 2 15 (39·5) 30 (46·9) 44 (44·9) 49 (49.5) 40 (39.6)
 Diffuse injury 3 or 4 14 (36·8) 10 (15·6) 22 (22·5) 23 (23.2) 23 (22.8)
 Mass lesion 9 (23·7) 24 (37·5) 32 (32·7) 27 (27.3) 38 (37.6)

ED CT scan, subarachnoid
 hemorrhage present, n (%)
26 (68·4) 44 (68·8) 68 (69·4) 71 (71.7) 67 (66.3)

ED CT scan, epidural hematoma
 present, n (%)
6 (15·8) 12 (18·8) 14 (14·3) 10 (10.1) 22 (21.8)

Surgery on admission, n (%) 9 (23.7) 22 (34.4) 30 (30.6) 26 (26.3) 35 (34.7)
 Epidural hematoma 0 3 (4.7) 6 (6.1) 3 (3.0) 6 (5.9)
 Subdural hematoma 7 (18·4) 19 (29·7) 20 (20.4) 20 (20.2) 26 (25.7)
Intracerebral
  hematoma/contusion
2 (5·3) 0 2 (2.0) 2 (2.0) 2 (2.0)
Non-CNS injury 0 0 2 (2.0) 1 (1.0) 1 (1.0)

Prehospital hypotension, n (%) 4 (10.5) 5 (7.8) 16 (16.3) 11 (11.1) 14 (13.9)

Prehospital hypoxia, n (%) 3 (7.9)** 7 (10.9) 29 (29.6) 18 (18.2) 21 (20.8)

Injury Severity Score, median
 (25th-75th)
27
(26-35)
29
(25-36.5)
29
(25-38)
29
(25-38)
29
(25-35)

IMPACT probability of poor
 outcome, mean (sd)
0.39 (0.3) 0.40 (0.2) 0.41 (0.3) 0.43 (0.3) 0.39 (0.3)

ED Hemoglobin (g/dl), median
 (25th-75th)
14.7
(13.5-15.6)
14.6
(12.8-15.5)
14.2
(12.7-15.6)
14.4
(13-15.6)
14.6
(12.8-15.5)

ED Glucose (mmol/L), median
 (25th-75th)
8.5
(7.2-10.7)
8.8
(7.1-10.1)
8.2
(6.9-10.1)
8.7
(7.3-10.4)
8.0
(6.-10.0)
a

Factors 1 and 2 include the same patients

b

motor GCS = motor component of the Glasgow Coma Score, which ranges from 1 (no motor response) to 6 (follows commands)

c

sum GCS = sum of the eye, motor, and verbal components of the Glasgow Coma Score, which ranges from 3 (no responses) to 15 (normal responses)